Skip to main content

Animations

MJFF Publications

4621 - 4630 of 6466 Results
Title
Year
  • Year
  • 2020
  • 2023
  • 2023
  • 2016
  • 2015
  • 2025
  • 2020
  • 2020
  • 2025
  • 2026
  • Summary Details
    OPEN
    Title: Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size and concentration
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/20013078.2020.1816641
    Citation Count: 138
  • Summary Details
    OPEN
    Title: Nigral Pathology Contributes to Microstructural Integrity of Striatal and Frontal Tracts in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29510
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2023.114370
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.338
    Citation Count: 612
  • Summary Details
    OPEN
    Title: Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.031
    Citation Count: 276
  • Summary Details
    OPEN
    Title: Radiosynthesis, In Vitro Characterization, and In Vivo PET Neuroimaging of [18F]F-4 for Tau Protein: A First-in-Human PET Study
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acschemneuro.4c00866
    Citation Count: 3
  • Summary Details
    OPEN
    Title: NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1909110117
    Citation Count: 147
  • Summary Details
    OPEN
    Title: Three-Plane–assembled Deep Learning Segmentation of Gliomas
    Journal Name: Radiology: Artificial Intelligence
    Publisher: Radiological Society of North America (RSNA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1148/ryai.2020190011
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Self-management for people with epilepsy and a history of negative health events (SMART): A randomized controlled effectiveness trial
    Journal Name: Epilepsy & Behavior
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.yebeh.2025.110495
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Autoradiography and preclinical PET studies with radiolabeled asyn-44 and ACI-12589 for imaging α-synuclein
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/1877718x261431108
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.